AI-generated summary
The authors report a pilot study of 11 patients with hard-to-heal wounds that had persisted at least two years, who received twice-weekly blue light photobiomodulation for four weeks alongside standard care. Wound area was reduced by week 12, with a mean decrease of 40.5 percent, and pain, exudate and surrounding skin improved over time. The authors note the findings warrant confirmation in larger, controlled studies.
- Participants
- 11
- Who or what was studied
- Patients with hard-to-heal venous, lymphatic, diabetic or mixed etiology wounds unhealed for at least two years, recruited from two outpatient clinics in Turin, Italy.
- Wavelengths
- 400, 430 nm
- Limits stated in the abstract
- The abstract describes a small pilot study with no control group, two participants lost at follow-up, and a week 4 area reduction that was not statistically significant.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background/Objectives
Hard-to-heal wounds are resistant to standard treatments and significantly impact patients' quality of life and healthcare costs. Photobiomodulation with blue light has shown potential in wound healing, but evidence in wounds persisting for extended periods is limited. This pilot study evaluated the effectiveness of an accelerated photobiomodulation protocol in patients with hard-to-heal wounds in a nurse-led outpatient setting.
Methods
Eleven patients with venous, lymphatic, diabetic, or mixed etiology wounds, unhealed for at least two years, were recruited from two clinics in the North District of the ASL Città di Torino. Participants received twice-weekly sessions of blue light photobiomodulation (EmoLED™, 400-430 nm lasting 60-120 s) for four weeks, in addition to standard care. The wound area was measured at baseline, week 4, and week 12 using the CutiMed Wound Navigator® Version 2.2.8. The secondary endpoints included pain, wound exudate quantity and quality, and the surrounding skin condition.
Results
All participants (average wound duration 5.9 years; mean area 13.1 cm2, SD ± 14.4) completed the treatment; two were lost at follow-up due to unrelated clinical events. No adverse reactions were reported. At week 4, an area reduction was shown in 9 of 11 wounds (mean: 9.5 cm2, SD ± 11.4), though not statistically significant (p = 0.240). At week 12, a significant reduction was observed (mean: 7.2 cm2, SD ± 13; p = 0.04), with a mean percentage area decrease of 40.5%. Significant improvements were also noted in pain levels, exudate characteristics, and surrounding skin conditions over time.
Conclusions
Accelerated blue light photobiomodulation appears to support long-term wound healing and symptom improvement in patients with hard-to-heal wounds. These findings warrant confirmation in larger, controlled studies.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 400-430 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Pilot study, Wound healing, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.